ISPOR Europe 2026
Panel Access and Pricing track
EU HTA System Readiness for Orphan Medicinal Products ahead of 13 January 2028
Mon, Nov 9, 2026 · 4:45–5:45 PM CET Hall F1, Level 0, Austria Center Vienna
About this session
The panel will explore different stakeholders’ perspectives on the readiness of the EU HTA system for OMPs that will become subject to JCA from 13 January 2028. Niklas Hedberg will provide the HTA body perspective and will speak to how OMPs will be assessed under the current methodological framework for JCAs.
Speakers
-
SERVIER
Panelist
